Earnings Releases·Nov 3, 2026, 8:20 AM ET

JBT Marel — Third Quarter 2026 Earnings Summary

Consolidated revenue declined 1% year-over-year to $994 million, while net income rose 6% to $70 million and adjusted EBITDA increased 5% to $179 million, driven by an improved adjusted EBITDA margin of 18.0%.
Full-year 2026 guidance was upgraded across all metrics, including revenue ($3,950M–$4,000M), adjusted EPS ($8.10–$8.40), and adjusted EBITDA margin (17.25%–17.50%), with revenue growth expected at approximately 5% at the midpoint.
The Board authorized a $500 million increase to the share repurchase program, raising total authorization to $700 million, following $94 million in buybacks during the quarter.
Segment performance showed mixed results with Protein Solutions revenue up 6% to $469 million, while Prepared Food and Beverage Solutions revenue fell 6% to $525 million due to lower CPG-related volume.
Net debt decreased to $1,694 million from $1,882 million at year-end 2025, resulting in a net debt-to-EBITDA ratio of 2.45x, with management targeting a long-term leverage range of 2.0x–2.5x.